carbenoxolone sodium has been researched along with Disease Exacerbation in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, JH; Hong, CH; Lee, KH; Lee, KS; Oh, BH; Shin, MJ | 1 |
Falk, S | 1 |
Doi, Y; Jin, S; Kawanokuchi, J; Li, E; Li, H; Liang, J; Mizoguchi, H; Mizuno, T; Mori, R; Noda, M; Parajuli, B; Sato, J; Sobue, G; Sonobe, Y; Suzumura, A; Takeuchi, H; Yamanaka, K; Yasuoka, S; Zhou, Y | 1 |
3 other study(ies) available for carbenoxolone sodium and Disease Exacerbation
Article | Year |
---|---|
Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Chemokine CXCL9; Cognition Disorders; Cytokines; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Humans; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Male; Polymers; Prognosis | 2008 |
Carbenoxolone as a novel therapy for attenuation of cancer-induced bone pain.
Topics: Analgesics; Animals; Bone Neoplasms; Cancer Pain; Carbenoxolone; Cell Line, Tumor; Connexins; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Male; Pain Measurement; Random Allocation; Rats; Spinal Cord; Statistics, Nonparametric; Weight-Bearing | 2018 |
Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Inflammatory Agents; Behavior, Animal; Carbenoxolone; Disease Progression; Female; Gap Junctions; Glycyrrhetinic Acid; Humans; Ion Channels; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Spinal Cord; Superoxide Dismutase | 2011 |